South Korea Biobanking Market Research Report By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Application (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End Use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations) and By Storage Type (Vapor Phase Storage, Liquid Phase Storage, Cryopreservation Storage)- Forecast to 2035

South Korea Biobanking Market Overview

As per MRFR analysis, the South Korea Biobanking Market Size was estimated at 98.6 (USD Million) in 2023.The South Korea Biobanking Market Industry is expected to grow from 102.8(USD Million) in 2024 to 250 (USD Million) by 2035. The South Korea Biobanking Market CAGR (growth rate) is expected to be around 8.414% during the forecast period (2025 - 2035).

Key South Korea Biobanking Market Trends Highlighted

The South Korea Biobanking Market is growing quickly because of new developments in biotechnology and a growing need for precision medicine. The South Korean government has been putting money into biobanking infrastructure to make it easier to collect and store biological samples. This is part of their focus on research and development. This stimulates collaboration between academic institutions, hospitals, and biotech enterprises, which plays a critical role in developing the biobanking ecosystem. 

Combining artificial intelligence with big data analytics is changing how samples are handled and analysed, which leads to more personalized healthcare treatments. There are a lot of chances in the South Korea Biobanking Market because chronic diseases are becoming more common and there is a need for a lot of genetic research. As personalized therapy becomes more important in healthcare, biobanks that can provide well-defined biological resources will be in great demand. Korea's robust rules for biobanks also follow global standards, which helps build international alliances and bring in foreign investment. 

More people are becoming aware of how important biobanking is, which is also a chance to get more people involved and support from the community. Recent trends show that biobanking is moving toward more ethical methods because of changes in the law and what people want.South Korea is putting informed consent and data privacy first to protect the rights of participants and build trust in the system. The country is a member of worldwide biobanking networks, which makes it easier for researchers to work together and exchange resources and results.

 To meet the increased demand for competent workers in this industry, programs are now being created to teach and train biobanking experts. The South Korean Biobanking Market is likely to keep growing because of new technologies, ethical concerns, and public interest.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South Korea Biobanking Market Drivers

Rising Demand for Personalized Medicine

The South Korea Biobanking Market Industry is experiencing significant growth due to the rising demand for personalized medicine. With the increasing focus on patient-centric healthcare, the demand for biobanks to provide genetic data for personalized treatment plans has escalated.

According to the South Korean government, the personalized medicine sector is projected to grow by over 10% annually, with advancements in genomics and biotechnology fueling innovations.Organizations such as the Korea National Biobank have been instrumental in collecting and storing biological samples that aid in Research and Development for personalized therapies, thereby enhancing the accessibility of targeted treatment solutions for various diseases such as cancer and cardiovascular conditions.

Growing Investment in Biotechnology and Genomic Research

In South Korea, substantial investment in biotechnology and genomic research catalyzes the growth of the South Korea Biobanking Market Industry. The South Korean government announced a robust investment strategy in biotechnology, amounting to approximately 2 billion USD over the next five years, aiming to bolster Research and Development activities across the sector. 

This influx of capital is anticipated to not only enhance biobanking infrastructure but also facilitate the creation of advanced biobanks that support extensive genomic research.Notable institutions like the Korea Institute of Science and Technology are at the forefront of these initiatives, promoting innovation and development in biobanking applications.

Increasing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases, such as diabetes and cancer, significantly drives the South Korea Biobanking Market Industry. According to the Korean National Health Insurance Service, cancer incidence rates have risen substantially, with an estimated 250,000 new cancer cases recorded annually. 

This alarming trend necessitates the establishment of biobanks that can provide high-quality biological samples for research aimed at understanding disease mechanisms and developing new treatments.As medical research continues to evolve, organizations like the Korean Cancer Association have begun collaborating with biobanks to better utilize these resources for disease prevention and management strategies.

Advancements in Laboratory Technology and Data Management

Technological advancements in laboratory equipment and data management systems play a crucial role in the growth of the South Korea Biobanking Market Industry. Innovative solutions in specimen processing, storage, and retrieval have streamlined biobanking operations, making them more efficient and reliable. 

The introduction of automated systems and improved bioinformatics tools facilitates better data collection and analysis, leading to enhanced research outcomes.According to a report by the Korean Society for Biochemistry and Molecular Biology, these advancements have led to a 50% increase in sample processing capacity in leading biobanks across the region, thus catering to the growing demand for biobank services.

South Korea Biobanking Market Segment Insights

Biobanking Market Sample Type Insights

The South Korea Biobanking Market has a lot of different parts, especially in the Sample Type category, which is quite important for how biobanks work as a whole. In this area, a wide range of biological samples are gathered and stored. These samples are very important for research and development, diagnostics, and personalized therapy. Blood products make up a large part of this market since they can be used in many different ways, such as in transfusions and as the basis for many clinical research investigations. 

Tissues taken from different origins help scientists learn more about how cells interact with one other and make progress in regenerative medicine and cancer research. Also, cells, especially stem cells, are being used to treat a wide range of disorders, which increases their need in this area. DNA and RNA are examples of nucleic acids that are very important for genetic research. They have led to advances in gene therapy and tailored treatment strategies. Researchers are also looking into microbiome samples to learn more about the close link between human health and microbial ecosystems. This is a new area of research in personalized medicine. 

The South Korean biobanking market has been moving toward these types of samples over time. This is because the government has been pushing for biobanks to be more important in healthcare innovation.This part of the market is set to increase a lot because of improvements in storage technology and more partnerships between biotech businesses and academic institutions. This is in line with worldwide trends in precision medicine and diagnostics. Different types of samples are important in different areas of research, showing how biobanking is important for improving treatment solutions. As biobanks in South Korea continue to grow, it is important to combine these sample types in order to make scientific discoveries and improve patient outcomes.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biobanking Market Application Insights

The Application segment of the South Korea Biobanking Market plays a crucial role in advancing healthcare and medical research within the region. This segment is primarily driven by factors such as increasing investments in Research and Development, which significantly enhances the understanding of diseases and the development of innovative treatments. Clinical Trials benefit immensely from biobanking, as access to diverse biological samples aids in producing more effective and targeted therapies. Personalized Medicine is gaining traction, as it leverages biobanked samples to tailor treatments individually, improving patient outcomes and satisfaction.

Additionally, Regenerative Medicine is emerging as a vital area, utilizing biobanked cells and tissues for innovative therapies that restore or replace damaged tissues and organs. The overall growth in the South Korea Biobanking Market is supported by a robust healthcare framework, government initiatives promoting research, and collaboration among institutions, making it a significant contributor to advancements in medical science. The potential for innovation in this area presents various opportunities, including enhanced patient care, improved diagnostic tools, and the development of cutting-edge therapies that address unmet medical needs.

Biobanking Market End Use Insights

The South Korea Biobanking Market is witnessing significant growth across its End Use segment, which encompasses a variety of critical players such as Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, and Government Organizations. Academic Research Institutions represent a substantial part of this market, as they engage in extensive studies that often require vast biobanked samples, driving advancements in genomics and personalized medicine. Biotechnology Companies are equally vital, utilizing biobanks to facilitate the development of novel therapeutics and diagnostic tools, thereby enhancing innovation.Pharmaceutical Companies leverage biobanks for Research and Development purposes, which allows them to conduct clinical trials more effectively by accessing a rich diversity of biological samples. 

Government Organizations play a crucial role by providing regulatory frameworks that support biobanking initiatives, which helps in promoting ethical standards while securing funding for research projects. The interplay among these segments contributes to the overall South Korea Biobanking Market revenue, positioning the country as a leader in biobanking within the region.The increasing focus on precision medicine and the growing need for data-driven approaches in healthcare are driving opportunities for growth and collaboration among these entities. As a result, the South Korea Biobanking Market segmentation continues to evolve, reflecting the diverse interests and needs of stakeholders involved in biobanking activities.

Biobanking Market Storage Type Insights

The Storage Type segment of the South Korea Biobanking Market plays a crucial role in preserving biological samples, which is pivotal for research and diagnostics. Within this segment, Vapor Phase Storage is significant due to its ability to maintain samples at ultra-low temperatures, minimizing cellular damage and maximizing sample integrity. Liquid Phase Storage also holds importance, particularly for tissues and other biological materials that require precise temperature control to remain viable over time. 

Cryopreservation Storage dominates in the biobanking sector since it facilitates long-term storage of cells, tissues, and even embryos, which is essential for regenerative medicine and fertility treatments.The advancements in storage technologies have further propelled the growth of this segment, aligning with the increasing emphasis on personalized medicine and Research and Development initiatives in South Korea's healthcare industry. As the demand for biological samples continues to rise, driven by trends in genomics and proteomics, the Storage Type segment is set to gain a larger share of the South Korea Biobanking Market, supporting the overall market growth and contributing to significant advancements in medical research and innovation.

South Korea Biobanking Market Key Players and Competitive Insights

The South Korea Biobanking Market is growing quickly because of new developments in biotechnology, a growing need for tailored medication, and a greater focus on research and development. There are many different types of companies in the competitive landscape, from big multinationals to small, specialized startups. Companies in this sector are working hard to build strong biobanking systems that make it easier to collect, store, and share biological samples for research. As biotechnology continues to grow, the biobanking industry is expected to improve its services and make its operations more efficient. 

This will create new chances for market participants to work together and come up with new ideas. The industry is much more competitive now that genomics and biotechnology technologies have improved. This has led to more investments and partnerships that are meant to speed up research projects and clinical applications. Kgenics is a leader in the South Korean biobanking market since it focuses so much on genomic analysis and tailored therapy. The organization has built a strong infrastructure for collecting and managing biological samples, which makes it easy for academics and healthcare practitioners to get high-quality samples for their studies. 

Kgenics wants to make the best use of biobanks in many scientific domains by using cutting-edge technology. This makes it a good choice for researchers looking for reliable sample sources. The company has formed strategic connections with research organizations and academic institutions, which has helped it become more well-known and solidify its place in the biobanking ecosystem in South Korea. Kgenics’ continual investment in technological improvements and collaboration reinforces its competitive position as a vital participant in the local industry. 

MedRex is another important player in the South Korea Biobanking Market. It focuses on storing and managing biological samples for a variety of research purposes. The organization provides comprehensive services, including sample collection, processing, and distribution, which are crucial for clinical trials and other research endeavours. MedRex has formed strategic agreements with a number of healthcare and research organizations, which has helped it grow in the biobanking field. 

The organization is known for its dedication to quality and following the rules, which makes sure that the samples it handles are of the greatest quality. MedRex is also actively involved in mergers and acquisitions, which helps it reach its growth goals and strengthens its presence in the South Korean market. As the biobanking industry changes, MedRex's focus on high-quality sample management and partnerships puts it in a good position to take advantage of new opportunities in the fast-growing healthcare and research markets.

Key Companies in the South Korea Biobanking Market Include:

• Kgenics


• MedRex


• Celltrion


• MediGene


• Sangamo Therapeutics


• Biogen


• Genexine


• Green Cross Corporation


• Korea Research Institute of Bioscience and Bioengineering


• HumGenome


• Theragen Etex


• Cure Genetics


• Sooam Biotech Holdings


• Hanlim Pharm


• Korea National Corporation

South Korea Biobanking Market Industry Developments

Recent developments in the South Korea Biobanking Market indicate significant growth and innovations. Companies such as Kgenics and MedRex are advancing their biobanking technologies, enhancing the quality of biological samples for research and clinical applications. In September 2023, Celltrion announced an expansion of its biobank facilities to accommodate an increase in demand for cell and gene therapies, representing an investment in developing personalized medicine strategies. 

Sangamo Therapeutics has been focusing on collaborations aimed at using its gene-editing technology for therapeutic development, thereby enhancing its biobanking capabilities. Furthermore, in August 2022, Biogen established a partnership with Theragen Etex to introduce precision medicine solutions utilizing advanced biobanking practices. Green Cross Corporation has recently invested in R&D to leverage biobanks for vaccine development, showcasing a heightened focus on public health. 

Growth in market valuations across these companies is underpinned by rising investments in biobanking for therapeutic advancements, with expectations of increased government support through initiatives from the Korea Research Institute of Bioscience and Bioengineering. Over the past few years, key events like the establishment of new biobanking regulations in March 2021 have also fostered a conducive environment for research and innovation within this market.

South Korea Biobanking Market Segmentation Insights

Biobanking Market Sample Type Outlook

• Blood Products


• Tissues


• Cells


• Nucleic Acids


• Microbiome Samples

Biobanking Market Application Outlook

• Research and Development


• Clinical Trials


• Personalized Medicine


• Regenerative Medicine

Biobanking Market End Use Outlook

• Academic Research Institutions


• Biotechnology Companies


• Pharmaceutical Companies


• Government Organizations

Biobanking Market Storage Type Outlook

• 
  

  Vapor Phase Storage

  
  


• 
  

  Liquid Phase Storage

  
  


• 
  

  Cryopreservation Storage

  
  

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	98.6(USD Million)
MARKET SIZE 2024	102.8(USD Million)
MARKET SIZE 2035	250.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	8.414% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Kgenics, MedRex, Celltrion, MediGene, Sangamo Therapeutics, Biogen, Genexine, Green Cross Corporation, Korea Research Institute of Bioscience and Bioengineering, HumGenome, Theragen Etex, Cure Genetics, Sooam Biotech Holdings, Hanlim Pharm, Korea National Corporation
SEGMENTS COVERED	Sample Type, Application, End Use, Storage Type
KEY MARKET OPPORTUNITIES	Increased personalized medicine demand, Expansion of genetic research initiatives, Rising collaborations with healthcare institutions, Government support for biobanking infrastructure, Growth in regenerative medicine applications
KEY MARKET DYNAMICS	Government regulations compliance, Growing demand for personalized medicine, Increased research funding initiatives, Emerging technologies adoption, Rising public awareness and participation
COUNTRIES COVERED	South Korea